152 related articles for article (PubMed ID: 6538259)
1. Modulation of cell-associated plasminogen activator activity by cocultivation of a stem cell and its tumorigenic descendant.
Liu HY; Yang PP; Toledo DL; Mangel WF
Mol Cell Biol; 1984 Jan; 4(1):160-5. PubMed ID: 6538259
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the plasminogen activator activity of a transformed cell line by cell density.
Liu HY; Peltz SW; Mangel WF
Mol Cell Biol; 1982 Nov; 2(11):1410-6. PubMed ID: 6819454
[TBL] [Abstract][Full Text] [Related]
3. Effect of retinoic acid on human neuroblastoma: correlation between morphological differentiation and changes in plasminogen activator and inhibitor activity.
Benjamin LA; McGarry RC; Hart DA
Cancer Chemother Pharmacol; 1989; 25(1):25-31. PubMed ID: 2590998
[TBL] [Abstract][Full Text] [Related]
4. Increased neurite development and plasminogen activator expression by exposure of human neuroblastoma cells to plasminogen-deficient growth medium.
Becherer PR; Wachsman JT
J Cell Physiol; 1980 Jul; 104(1):47-52. PubMed ID: 7192289
[TBL] [Abstract][Full Text] [Related]
5. In vitro differentiation of teratomas and the distribution of creatine phosphokinase and plasminogen activator in teratocarcinoma-derived cells.
Topp W; Hall JD; Marsden M; Teresky AK; Rifkin D; Levine AJ; Pollack R
Cancer Res; 1976 Nov; 36(11 Pt. 2):4217-23. PubMed ID: 184930
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of the activation of plasminogen by natural and recombinant tissue-type plasminogen activator.
Zamarron C; Lijnen HR; Collen D
J Biol Chem; 1984 Feb; 259(4):2080-3. PubMed ID: 6538196
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activators in tissues of the immature and estrogen-stimulated rat uterus and in uterine luminal fluid: characterization and properties.
Peltz SW; Katzenellenbogen BS; Kneifel MA; Mangel WF
Endocrinology; 1983 Mar; 112(3):890-7. PubMed ID: 6681601
[TBL] [Abstract][Full Text] [Related]
8. Purification and characterization of the plasminogen activator secreted by a rat brain tumor cell line in culture.
Bykowska K; Rijken DC; Collen D
Thromb Haemost; 1981 Oct; 46(3):642-4. PubMed ID: 7198301
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of plasminogen activator and plasminogen activator inhibitor by osteotropic factors in primary cultures of mature osteoblasts and osteoblast precursors.
Pfeilschifter J; Erdmann J; Schmidt W; Naumann A; Minne HW; Ziegler R
Endocrinology; 1990 Feb; 126(2):703-11. PubMed ID: 2298166
[TBL] [Abstract][Full Text] [Related]
10. Modulation of proteolytic activity during neuritogenesis in the PC12 nerve cell: differential control of plasminogen activator and plasminogen activator inhibitor activities by nerve growth factor and dibutyryl-cyclic AMP.
Leprince P; Rogister B; Delrée P; Rigo JM; André B; Moonen G
J Neurochem; 1991 Aug; 57(2):665-74. PubMed ID: 1649256
[TBL] [Abstract][Full Text] [Related]
11. The state of differentiation of HT-29 colon carcinoma cells alters the secretion of cathepsin D and of plasminogen activator.
Huet G; Zerimech F; Dieu MC; Hemon B; Grard G; Balduyck M; Janin A; Lafyatis R; Degand P
Int J Cancer; 1994 Jun; 57(6):875-82. PubMed ID: 7911458
[TBL] [Abstract][Full Text] [Related]
12. Cell density-dependent secretion of plasminogen activator by 3T3 cells.
Chou IN; O'Donnell SP; Black PH; Roblin RO
J Cell Physiol; 1977 Apr; 91(1):31-7. PubMed ID: 404303
[TBL] [Abstract][Full Text] [Related]
13. Rat mammary carcinoma cells secrete active collagenase and activate latent enzyme in the stroma via plasminogen activator.
O'Grady RL; Upfold LI; Stephens RW
Int J Cancer; 1981 Oct; 28(4):509-15. PubMed ID: 6273336
[TBL] [Abstract][Full Text] [Related]
14. Regulation of plasminogen activator secretion in mouse peritoneal macrophages. I. - Role of serum studied by a new spectrophotometric assay for plasminogen activators.
Drapier JC; Tenu JP; Lemaire G; Petit JF
Biochimie; 1979; 61(4):463-71. PubMed ID: 486577
[TBL] [Abstract][Full Text] [Related]
15. The plasminogen-plasminogen activator (PA) system in neuroblastoma: role of PA inhibitor-1 in metastasis.
Sugiura Y; Ma L; Sun B; Shimada H; Laug WE; Seeger RC; DeClerck YA
Cancer Res; 1999 Mar; 59(6):1327-36. PubMed ID: 10096567
[TBL] [Abstract][Full Text] [Related]
16. Modulation of plasminogen activators and plasminogen activator inhibitors by TGF-beta, IL-1 alpha and EGF in fetal rat calvaria cells at different times of culture.
Laschinger CA; Bellows CG; Wasi S
Bone Miner; 1991 Apr; 13(1):23-34. PubMed ID: 2065216
[TBL] [Abstract][Full Text] [Related]
17. Purification and properties of a plasminogen activator from cultured rat prostate adenocarcinoma cells.
Strickland DK; de Serrano VS; Chan SY; Pollard M; Castellino FJ
Biochemistry; 1983 Sep; 22(19):4444-9. PubMed ID: 6684952
[TBL] [Abstract][Full Text] [Related]
18. Hormonal regulation of extracellular plasminogen activators and Mr approximately 54,000 plasminogen activator inhibitor in human neoplastic cell lines, studied with monoclonal antibodies.
Andreasen PA; Christensen TH; Huang JY; Nielsen LS; Wilson EL; Danø K
Mol Cell Endocrinol; 1986 May; 45(2-3):137-47. PubMed ID: 3011558
[TBL] [Abstract][Full Text] [Related]
19. Laminin interacts with plasminogen and its tissue-type activator.
Salonen EM; Zitting A; Vaheri A
FEBS Lett; 1984 Jun; 172(1):29-32. PubMed ID: 6428936
[No Abstract] [Full Text] [Related]
20. Altered expression of gelatinase and surface-associated plasminogen activator activity by trophoblast cells isolated from placentas of preeclamptic patients.
Graham CH; McCrae KR
Am J Obstet Gynecol; 1996 Sep; 175(3 Pt 1):555-62. PubMed ID: 8828413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
